|
|
42
|
|
|
A231AE
|
|
|
GABAPENTIN 300MG CAP (FSB)
|
|
|
GABAPENTIN
|
|
|
GABAPENTIN
|
|
|
100'S
|
|
|
A
|
|
|
7.04
|
|
|
0.07
|
|
|
300MG
|
|
|
CAP
|
|
|
180
|
|
|
|
|
|
FSB
|
|
|
FLAGSHIP BIOTECH
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
B
|
|
|
Anti-Epileptic
|
|
|
2026-04-01
|
|
|
2028-03-31
|
|
|
No
|
|
|
No
|
|
|
|
|
|
0
|
|
|
N
|
|
|
281292
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
|
ORAL
|
|
|
6
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
2026-03-05
|